Advertisement

The Latest

Texas was named the worst state for mental healthcare in the U.S. for the second year in a row, according to a ranking from Forbes Advisor.

The FDA's Psychopharmacologic Drugs Advisory Committee will consider whether to recommend approval for a psychedelic treatment for post-traumatic stress disorder. 

The Substance Abuse and Mental Health Services Administration launched a funding opportunity that will invest up to $1.48 billion to U.S. states and $63 million to tribes to combat the substance use crisis. 

Advertisement